- Humana Inc (NYSE:HUM) has posted Q1 adjusted sales of $24.08 billion, beating the consensus of $23.51 billion.
- The benefits expense ratio increased from 86.4% to 85.9%, and the operating cost ratio increased from 12% to 9.7%.
- Humana posted an adjusted EPS of $8.04, beating the consensus of $6.78 and $6.38 posted a year ago.
- Related: Humana to Offload Substantial Stake In Kindred At Home Hospice & Personal Care Divisions.
- Guidance: Humana expects FY22 GAAP EPS of at least approximately $24.50, up from prior guidance of $24, versus the consensus of $24.17.
- The updated guidance includes a $1.00 embedded COVID headwind and the estimated dilutive impact related to the pending divestiture of Humana's 60% stake in Kindred at Home's Hospice and Personal Care divisions.
- The Company reaffirms FY 2022 expected individual Medicare Advantage membership growth range of approximately 150,000 to 200,000.
- Price Action: HUM shares are up 3.18% at $444.17 during the market session on the last check Wednesday.
Get all your news in one place.
100’s of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100’s of premium titles. One news app.
Humana Q1 Earnings Beats Expectations, Raises FY22 Profit Guidance
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member?
Sign in here
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member?
Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member?
Sign in here
Our Picks